Objectives:
Introduction
A basic feature of heart failure is the structural remodeling of the heart characterized by hypertrophy of the cardiomyocytes, fibroblast proliferation and increased synthesis of collagen leading to fibrosis and decreased compliance. Heart failure [1,2] and myocardial ischemia [3] are accompanied by an increase in circulating plasma endothelin (ET), a potent vasoconstrictor peptide originally isolated from cultured endothelial cells [4] . Interestingly, ET has been shown in vitro to promote hypertrophy of isolated cardiomyocytes [5, 6] , fibroblast proliferation [7] and increased synthesis of collagen [g] . Moreover, ET has been 602 T. T@nnessen et al. / Cardiotiascular Research 33 (1997) [601] [602] [603] [604] [605] [606] [607] [608] [609] [610] increase in ET might be counterbalanced by receptor downregulation. To get insight into how the ET receptors are regulated in ischemic heart failure, another aim of the present study was to examine cardiac mRNA levels for the ET, and ET, receptors.
Methods

I. Animal preparation
Male Wistar rats (250-300 g>, weighed immediately before the primary operation, were anesthetized with a mixture of 30% O,, 70% N,O, and 4% halothane (Zeneca, Macclesfield Cheshire, UK). After induction of anesthesia, the rats were intubated and connected to a ventilator (Model 874092, B. Braun, Melsungen, Germany), and ventilated with a mixture of 30% O,, 70% N,O, and 1% halothane. In animals undergoing myocardial infarction, the heart was exposed through a left thoracotomy after removal of the fourth rib. After opening of the pericardium, the heart was rapidly and gently exteriorized and the left coronary artery ligated by a silk suture as described elsewhere [12] . The heart was subsequently returned to its normal position in the thorax, and the thoracotomy was closed by a string suture during maximum inspiration. The sham-operated animals were subjected to the same surgical procedure, with the only difference that the left coronary artery was left unligated. All rats were given 0.05 ml buprenorphin (0.3 mg/ml) S.C. after the operation.
The second operation was performed 1 or 6 weeks after the first operation. Arterial systolic pressure and left ventricular end-diastolic pressure were recorded in all groups by a 2F micromanometer-tipped catheter (Model SPR-407, Millar Instruments Inc., Houston, TX) inserted through the right carotid artery and connected to a Hewlett Packard amplifier (Model 78304 A) and a Hewlett Packard graphic recorder (Model 78171 A). In animals undergoing myocardial infarction, only those with a left ventricular end-diastolic pressure above 15 mmHg were considered to be in heart failure and were included in the study. The rats were sacrificed by excision of the heart which was immediately sectioned into atrial, left and right ventricular tissue and snap-frozen in liquid nitrogen, weighed, and stored at -70°C. Immediately prior to excision of the heart, blood for analysis of plasma ET was obtained from the abdominal aorta through a midline incision.
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1985).
Experimental procedure
The animals were allocated to one of 4 groups: (1) animals undergoing myocardial infarction by ligation of the left coronary artery and to be sacrificed after 1 week (n = 7); (2) sham-operated animals to be sacrificed after 1 week (n = 9); (3) animals undergoing myocardial infarction to be sacrificed after 6 weeks (n = 7); and (4) shamoperated animals to be sacrificed after 6 weeks (n = 6). In addition, unoperated, age-matched rats housed for the same period of time under the same environmental conditions, were included for comparison and sacrificed after 1 (n = 6) and 6 (n = 4) weeks, respectively.
Northern blot analyses of RNA from left ventricles of 15 hearts obtained from rats sacrificed after 1 week (6 hearts in heart failure, 6 hearts from sham-operated and 3 hearts from unoperated rats) and 14 hearts obtained from rats sacrificed after 6 weeks (4 hearts in heart failure, 6 hearts from sham-operated and 4 hearts from unoperated rats) were performed. To achieve the amounts of RNA required for the Northern blot analyses of atria1 and right ventricular tissue, atria1 and right ventricular tissues from 2-6 rats were pooled.
Plasma ET was determined in all rats sacrificed after 6 weeks and in all but one unoperated rat sacrificed after 1 week. Body weight, atrial, right and left ventricular weights, and left ventricle to body weight ratio were determined in all animals when being sacrificed.
Ribonuclease (RNAase) protection assay was performed on left ventricles of 4 rats from group 1 in heart failure 1 week after induction of myocardial infarction and of 2 sham-operated rats from group 2. In 6 additional rats, we examined whether the ET-l n-RNA expression in the left ventricle of failing hearts was most abundant in the area subjected to myocardial infarction or in the non-infarcted area after 1 week. In those 6 rats, the left ventricles were sectioned into the macroscopically infarcted area and the non-infarcted area and both parts were subjected to RNAase protection assay.
Chemicals and cDNAs
[o-32 PI-dCTP and [ OL-32 PI-CTP were from DuPont-New England Nuclear, Inc. Custom-made oligodeoxynucleotides were purchased from Pharmacia Biotech Ltd. Oligo-dT-conjugated paramagnetic beads (Oligo-dT Dynabeads) were from Dynal A/S (Oslo, Norway). The prepro-endothelin-1 cDNA was kindly provided by Dr. Masaki and Dr. Sawamura. The proANF cDNA was kindly provided by Dr. Glembotski.
Construction of cDNA probes
An 1100 bp EcoRI/NarI restriction fragment of the rat prepro-endothelin-1 cDNA was nick-translated in the presence of [cx-~'P]-~CTP and used as probe in Northern blot analysis (specific activity 0.5-1.0 X 10' cpm/p,g). A 650 bp EcoRI/HindIII restriction fragment of the rat proANF cDNA was radiolabeled by nick-translation (specific activity approximately 1.0 X 10' cpm/p,g) and used as probe in Northern blot analysis of ANF mRNA. The glyceralde- hyde-3-phosphate dehydrogenase (GAPDH) cDNA and prepro-endothelin-3 cDNA were amplified from mRNA from the left ventricular cardiac tissue by RT-PCR, subcloned into pBluescript SK + and sequenced by the dideoxy chain termination technique [13] . A fragment of the rat ET, and ET, receptors corresponding to the fragment between the third and sixth transmembrane loops were amplified by RT-PCR from mRNA from the left myocardium, subcloned into PCRscript (Stratagene, CA) and verified by DNA sequencing using the dideoxy chain termination technique.
Northern blot analysis
Total RNA from rat cardiac tissues was prepared by the guanidinium isothiocyanate/CsCl method [14,15], phenol/chloroform-extracted, and ethanol-precipitated. The RNA yield was somewhat less from left ventricles of hearts in heart failure than that of sham-operated rats. Poly A+ RNA was purified from total RNA using oligo-dTconjugated paramagnetic beads according to the manufacturer's instructions (Dynal A/S, Oslo, Norway). The poly A+ RNA was denatured in 50% formamide (v/v> and 6.5% formaldehyde (v/v), and size-fractionated on a formaldehyde-agarose gel using 4 kg poly A+ RNA/lane, transferred to a nylon filter membrane by capillary blotting and hybridized with radiolabeled cDNA probes for prepro-ET-l, prepro-ET-3, proANF, GAPDH, ET, or ET, receptors. The nylon membranes were hybridized at 42°C for 12 h in 5 X SSC, 5 X Denhardt's solution, 50% formamide, 50 mM sodium phosphate, pH 6.5, 125 pg/ml sonicated salmon sperm DNA, and 2-3 X lo6 cpm of nick-translated cDNA probe (specific activity 0.5-1.0 X lo9 cpm/pg). The stringent wash was performed at 60°C in 0.1 X SSC, 0.1% SDS, pH 7.0. Autoradiography of the filters was carried out at -70°C and the films were analyzed by densitometric scanning analysis using the ImageMaster software from Pharmacia Biotech Ltd. The data were subsequently corrected for variations in RNA loading by normalizing mRNA expression levels to the GAPDH mRNA expression in each sample.
RNAase protection assay
A continuously labeled antisense RNA transcript to ET-l was generated by in vitro transcription using T7 RNA polymerase and [o-32P]-CTP (6000 Ci/mmol). The probe protected a 350 bp fragment of rat ET-1 mRNA. For analysis of mRNA, 40 pg of total RNA was precipitated together with radiolabeled probe and dissolved in the hybridization buffer (80% formamide, 40 mM PIPES, 400 mM sodium chloride, 1 mM EDTA, pH 8). Hybridization was performed overnight at 50°C. RNAase digestion was then carried out at 37°C for 30 min and terminated by the addition of proteinase K (1 mg/ml) with 3% SDS, phenol-chloroform extraction and ethanol precipitation of the RNA. The precipitated RNA was subsequently dissolved in 80% formamide running buffer and separated on a 5% denaturing polyacrylamide gel using equal loading conditions. After electrophoresis the gel was dried and autoradiography carried out at -70°C. The intensity of the bands was analyzed by densitometric scanning analysis using the ImageMaster software from Pharmacia Biotech Ltd.
Plasma ET determination
Plasma ET was analysed as described previously [16] . Briefly, arterial blood was collected directly into prechilled test-tubes containing EDTA (4.1 mM final concentration), kept on ice, and centrifuged within 10 min at 1700 X g for 10 min at 4°C. The samples were stored at -20°C until analyzed. ET was extracted from 1 ml plasma added to 6.0 ml of 4% acetic acid on Sep-Pak Cl8 cartridges (Waters Chromatography Division, Milford, MA). The cartridges were prewashed with 10 ml of 86% ethanol and 10 ml of 4% acetic acid. The extract was evaporated to dryness with nitrogen at 37°C and dissolved in 500 pl 0.02 M borate buffer. Radio-immunoassay was performed using an endothelin l-2 1 specific [ '*9] assay system (RPA 555) from Amersham International (Cardiff, UK). This assay system has no cross-reactivity with big endothelin, 144 and 52% cross-reactivity with ET-3 and ET-2, respectively. The Values are means + s.e.m. BWB = body weight before primary surgery; BWS = body weight when sacrificed; W = weight; LVW = left ventricular weight; BWB and BWS are given in grams, whereas heart weights are given in milligrams. * P < 0.05 vs. sham-operated animals.
at Pennsylvania State University on February 23, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from recovery of the extraction, based on the native ET-I peptide, averaged 75%. Both the interassay and intra-assay variation coefficients are below 10%.
Statistical analyses
Values are given as means -t s.e.m. For comparison between groups we used the Mann-Whitney rank sum test, and the Wilcoxon signed rank sum test was used for comparison of paired data. Correlation between mRNA expression and left ventricular end-diastolic pressure was calculated using linear regression analysis with the leastsquare method. A P-value of < 0.05 was considered as statistically significant.
Results
Weight
Mean body weights, heart weights and heart to body weight ratios in the various groups are shown in Table 1 . In rats sacrificed 1 week after induction of myocardial infarction, atria1 tissue weights were significantly higher man in sham-operated animals. After 6 weeks the atria1 weights, the weights of the right ventricles and the left ventricle to body weight ratios were all significantly higher in rats with heart failure than in sham-operated rats.
Hemodynamic measurements
Arterial systolic pressures and left ventricular end-diastolic pressures are shown in Table 2 . Both in rats sacrificed 1 and 6 weeks after induction of myocardial infarction, there were significantly lower arterial systolic pressures and higher left ventricular end-diastolic pressures. The left ventricular end-diastolic pressures were significantly higher in rats with myocardial infarction sacrificed after 6 weeks than in those sacrificed after 1 week. Fig. 1 . Northern blots of RNA from left ventricular tissues showing mRNA levels of prepro-endothelin-1 (ppET-11, atria1 natriuretic factor (ANF) and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) in unoperated rats, sham-operated rats, and rats in ischemic heart failure 1 week after induction of myocardial infarction. Autoradiography was performed at -70°C for 12 days for ET-I, 24 h for ANF and 15 h for GAPDH. Lower panel shows the results of the densitometric scanning analyses of the different lanes with the relative intensities of the ppET-1 mRNA levels (ppET-1 mRNA/GAPDH mFWA) given on the ordinate. Open bars = unoperated rats; hatched bars = sham-operated rats; solid bars = rats in heart failure.
3.3. ET-I mRNA expression 3.3.1. One week after myocardial infarction Northern blot analyses revealed a very low expression of ET-l mRNA in the normal left ventricular tissue of sham-operated rats 1 week after the primary operation and in the age-matched unoperated rats (Fig. 1) . In strong contrast, an upregulation of ET-l mRNA levels was observed in the left ventricle of all the failing hearts 1 week after induction of myocardial infarction (Fig. 1) . The upregulation averaged 10.6 + 4.0-fold (P = 0.002) compared to sham-operated animals, and ranged from 4-fold to 27-fold. Left ventricular ET-l mRNA expression correlated significantly with left ventricular end-diastolic pressure in the failing hearts 1 week after induction of myocardial infarction (r' = 0.86, P = 0.007). There was also a 2.0 * 0.1 -fold and a 1.9 f 0.6fold upregulation of ET-1 mRNA levels in atria1 and right ventricular tissue, respectively (Fig. 2) .
We also performed a RNAase protection assay on tissues from left ventricles. The results of the RNAase protection assay were in accordance with those of the Northem blot studies and showed a 12.4 &-5.2-fold mean upregulation of ET-l mRNA in the left ventricles of failing hearts compared to hearts from sham-operated rats (Fig.  3) .
To examine whether the ET-l mRNA expression in the left ventricles of failing hearts was most abundant in the area subjected to myocardial infarction or in the non-infarcted area, the RNAase protection assay was performed on tissues from both areas. A 2.8 f O.Cfold higher expression of ET-I mRNA was observed in the infarcted area than in the non-infarcted area (Fig. 4 , P < 0.03).
ET-l mRNA expression was measured in the left ventricles of the failing hearts compared to those of the shamoperated rats. This increase in cardiac ET-l mRNA levels was significantly less than that observed after 1 week (P < 0.02). After 6 weeks no correlation between left ventricular ET-l mRNA expression and left ventricular end-diastolic pressure was found. Atria1 and right ventricular tissues also showed an increased mRNA expression which was 3.3 + 0.3-and 5.5 f 0.8-fold in the two tissues, respectively.
ET, and ET, receptor mRNA expression 3.3.2. Six weeks after myocardial infarction
To examine whether there was a compensatory downTo evaluate the time course of ET-1 upregulation in regulation of ET receptor mRNA as a response to the heart failure, ET-l mRNA levels were also examined 6 increase in ET-1 expression, both ET, and ET, receptor weeks after induction of myocardial infarction. At this mRNA levels were examined in the left ventricles of time point only a modest upregulation of ET-l mRNA unoperated and sham-operated rats, as well as in rats in levels was observed in the left ventricles of the failing heart failure 1 week after myocardial infarction (Fig. 6 ). hearts (Fig. 5) . A 2.7 f 0.5-fold (P < 0.05) increase of Although the data were not statistically significant, there AU AS AIHF 18'9 4 ppET-1 mRNA 18s B 4 CAPDH Fig. 2 . Northern blots of RNA from right ventricular and atria1 tissues showing mRNA levels of prepro-endothelin-1 (ppET-1). and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH). RU = right ventricular tissue from unoperated rats; RS = right ventricular tissue from sham-operated rats; RIHF = right ventricular tissue from rats in ischemic heart failure 1 week after induction of myocardial infarction. AU = atrial tissue from unoperated rats; AS = atria1 tissue from sham-operated rats; AIHF = atria1 tissue from rats in ischemic heart failure. Autoradiography was performed at -70°C for 12 days for ET-l and 15 h for GAPDH. Lower panel shows the results of the densitometric scanning analyses of the different lanes with the relative intensities of the ppET-1 mRNA levels (ppET-1 mRNA/GAPDH mRNA) given on the ordinate. Open bars = unoperated rats; hatched bars = sham-operated rats; solid bars = rats in heart failure. Natriuretic Factor (ANF) and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) in unoperated rats, sham-operated rats, and rats in ischemic heart failure 6 weeks after induction of myocardial infarction. Autoradiography was performed at -70°C for 12 days for ET-l, 24 h for ANF and 15 h for GAPDH. Lower pane1 shows the results of the densitometric scanning analyses of the different lanes with the relative intensities of the ppET-1 mRNA levels (ppET-1 mRNA/GAPDH mRNA) given on the ordinate. Open bars = unoperated rats; hatched bars = sham-operated rats; solid bars = rats in heart failure.
ANF mRNA expression
ANF mRNA expression in the left ventricles of the failing hearts was determined both 1 week and 6 weeks after induction of myocardial infarction and compared to the corresponding sham-operated animals. After 1 week, the left ventricular ANF expression was increased 34.8 ? 11.3-fold (P < 0.05) compared to sham-operated animals (Fig. 1) . In he rt a s obtained 6 weeks after induction of myocardial infarction, there was a 143.6 f. 23. l-fold (P < 0.01) increase in left ventricular ANF expression (Fig. 5 ).
Plasma ET
Arterial plasma ET concentrations were significantly increased in rats with ischemic heart failure compared to sham-operated rats 6 weeks after induction of myocardial infarction. The mean plasma ET levels in the two groups were 13.3 + 0.9 and 10.9 f 0.8 fmol/ml, respectively (P < 0.05). In the unoperated rats, the mean plasma ET was 10.6 f 1.2 fmol/ml. In rats sacrificed 1 week after induction of myocardial infarction, the plasma ET was 12.1 f 0. sham-operated rats, and rats in ischemic heart failure 1 week after induction of myocardial infarction. Autoradiography was performed at -70°C for 12 days. Lower panel shows the results of the densitometric scanning analyses of the different lanes with the relative intensities of the ET, receptor mRNA (ET, mRNA/GAPDH mRNA) and ET, receptor mRNA (ET, mFUVA/GAPDH mRNA) levels given on the ordinate. Open bars = unoperated rats; hatched bars = sham-operated rats; solid bars = rats in heart failure. fmol/ml in the group with heart failure and 10.9 + 0.9 fmol/ml in the sham-operated group. However, the increased plasma levels 1 week after myocardial infarction did not reach statistical significance. In unoperated rats sacrificed after 1 week, plasma ET was 10.2 + 0.4 fmol/ml.
Discussion
This study reports increased cardiac ET-l mRNA expression in ischemic heart failure in rats, indicating de wuo synthesis of endothelin in the heart. The highest levels of left ventricular ET-l mRNA were found 1 week after induction of myocardial infarction, and the infarcted area showed a 3-fold higher ET-l expression than the non-infarcted area. Only a modest increase in left ventricular ET-l mRNA was observed 6 weeks after myocardial infarction. Left ventricular ET-l mRNA expression correlated significantly with left ventricular end-diastolic pressure after 1 week, suggesting that cardiac ET expression can be linked to the degree of heart failure.
In the present study, heart failure in rats subjected to myocardial infarction was indicated by both increased left ventricular end-diastolic pressure and increased cardiac ANF mRNA expression which is considered to be a transcriptional marker for cardiac hypertrophy and heart failure [ 17,l S] . Heart failure is characterized by increased mechanical stress in the myocardium and activation of neurohumoral factors. Both mechanical stress and neurohumoral factors might induce cardiac ET-l synthesis in heart failure. It has been shown that mechanical stretch induces ET production in vitro [19] . Moreover, another in vitro study has reported increased ET synthesis by cells subjected to an increase in pressure [20] . Thus, an increased ET-l mRNA synthesis induced by enhanced me- chanical stress might explain the correlation between ET-l expression and left ventricular end-diastolic pressure in the present study. This is also in accordance with a recent study [21] published during the preparation of this manuscript. In that study, which reported an increased ET production in the heart and in plasma of rats with heart failure, plasma ET correlated positively with LVEDP and infarct size. However, they measured ET only in the non-infarcted area of the heart. In the present study, we measured increased expression of ET-1 mRNA in the infarcted area compared to the non-infarcted area of the heart. Thus, in addition to mechanical stress, ischemia and reparative processes might be responsible for this finding by inducing ET-I mRNA synthesis in the infarcted area. Humoral factors might also induce cardiac ET-1 expression in heart failure. Angiotensin II and catecholamines are increased in heart failure [22, 23] , and both have been shown to induce synthesis of ET by endothelial cells in vitro [4, 24] . Moreover, in cultured cardiomyocytes angiotensin II has been shown to upregulate ET-l mRNA expression [25] . Vasopressin is also increased in heart failure [26] and has been shown to facilitate ET production by both smooth muscle cells [27] and endothelial cells in vitro [28] . However, whether humoral factors are involved in the increased cardiac ET-l mRNA expression during heart failure needs further investigations.
In the present study, the increase in ET-l mRNA was more pronounced 1 week after myocardial ischemia than after 6. A similar pattern with a transient increase in cardiac ET-l mRNA expression has been found in a study by Ito and co-workers in another model of myocardial stress [17] . In their model of aortic banding, cardiac afterload was abruptly increased by placing a ligature around the abdominal aorta, and a transient upregulation of cardiac ET-l mRNA was observed in the first days after the procedure. In our study, the transient upregulation of ET-l mRNA contrasts with the upregulation of ANF mRNA, where the highest levels were found 6 weeks after myocardial infarction. Although the plasma levels of both peptides have been shown to correlate to cardiac filling pressure , the cardiac expression of ANF and ET-l mRNA in ischemic heart failure in the present study appears to be regulated differently. The decline of ET-l mRNA 6 weeks after myocardial infarction as compared to that after 1 week might be explained by a negative feedback mechanism of ET-l or that cardiac ET-l synthesis is suppressed by the high levels of ANF found after 6 weeks (144-fold compared to sham). The latter explanation is supported by studies showing an inhibitory effect of ANF on ET synthesis in vitro [33, 34] .
Arterial plasma ET was not significantly increased 1 week after induction of myocardial infarction although cardiac ET-1 mRNA levels on average exhibited an 1 l-fold increase. These findings are in accordance with those of Arai and colleagues who found an increase in mature ET-1 levels in cardiac ventricular tissue measured by sandwich enzyme immunoassay 1 week after increasing myocardial stress by aortic banding, whereas no accompanying increase was found in plasma ET 1351. After 6 weeks, we found a significant increase in plasma ET although the increase in cardiac ET-l mRNA levels was modest. Thus, the contribution of cardiac ET production to arterial plasma ET levels is questionable. More likely our findings could be explained by an increased extra-cardiac ET production. The altered hemodynamic or hormonal state during heart failure might induce ET production in the peripheral circulation.
In heart failure adrenergic receptor mRNA levels are downregulated as a response to the increased levels of catecholamines following activation of the sympathetic nervous system [36, 37] . The accompanying receptor downregulation [38, 39] has been shown to reduce the sensitivity to catecholamines in this disease. ET receptor mRNA levels do not seem to follow the same pattern of regulation. Neither ET, nor ET, receptor mRNA expression was reduced in the failing hearts, indicating that ET receptor synthesis is not downregulated. Rather, there was a tendency to increased ET receptor synthesis, which is in accordance with another study [21] that reported an increase in ET-l binding sites in hearts from rats in congestive heart failure. The findings of that study and the present study support an autocrine or paracrine role for ET in heart failure, since a downregulation of receptor synthesis would be expected to counteract the effects of an increase in ET.
The increase in cardiac ET-l mRNA expression with subsequent ET de nuvo synthesis might have important pathophysiological implications. Increased plasma ET in patients in the subacute phase after myocardial infarction has been shown to be a very strong and independent predictor of the l-year mortality [40] . In fact, ET-l was found to be a stronger predictor of mortality in myocardial infarction than any of the previously known biochemical and hemodynamic predictors of mortality from this disease. Moreover, in vitro studies have shown that ET induces hypertrophy of cardiomyocytes [5, 6] , stimulates fibroblast proliferation [7] and increases the synthesis of collagen [8] . In an in vivo study, ET receptor blocking agents have been shown to reduce myocardial hypertrophy 1 week after increasing cardiac afterload by aortic banding [17] . The findings of these studies taken together with those of the present study make it tempting to speculate that ET is implicated in an autocrine/paracrine manner in the pathologic remodeling taking place in ischemic heart failure. Our finding of increased cardiac ET-l mRNA expression in the early phase of the development of heart failure might provide an important clue to the understanding of the pathophysiology of ischemic heart failure and a goal for future pharmacological intervention. However, further studies need to be undertaken to reveal the exact pathophysiological role for ET in heart failure.
In conclusion, ischemic heart failure in rats is associ-ated with a substantial increase in cardiac expression of ET-l mRNA 1 week after myocardial infarction, and a 3-fold higher ET-l mRNA expression is measured in the infarcted area of the left ventricle than in the non-infarcted area. Only a modest increase in cardiac ET-l mRNA is observed after 6 weeks. The increase in left ventricular ET-l mRNA correlates significantly with the increase in left ventricular end-diastolic pressure 1 week after induction of myocardial infarction. ET, and ET, receptor mRNA levels are not downregulated. Taken together these findings might indicate an autocrine/paracrine role for ET-l in ischemic heart failure in rats.
